BTIG Research initiated coverage on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research note issued to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $55.00 price target on the biotechnology company’s stock. A number of other analysts have also recently issued reports on ANAB. StockNews.com cut shares of […]
Stifel Nicolaus started coverage on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research note published on Wednesday, Marketbeat reports. The firm issued a buy rating and a $50.00 price objective on the biotechnology company’s stock. Other equities analysts have also recently issued reports about the stock. StockNews.com cut shares of AnaptysBio from a […]
Stifel Nicolaus started coverage on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a report issued on Wednesday, Marketbeat reports. The brokerage issued a buy rating and a $50.00 target price on the biotechnology company’s stock. Other equities analysts have also recently issued reports about the stock. StockNews.com cut shares of AnaptysBio from a hold […]
Shares of AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) have been given an average rating of “Hold” by the five research firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price […]
Shares of AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) have been given an average recommendation of “Hold” by the five analysts that are currently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price […]